多发性硬化SF-36的影响因素分析

目的探讨多发性硬化(MS)"健康调查简易量表"(SF-36)的影响因素。方法对比分析MS不同间歇期、发作期、Zung抑郁自评量表(SDS)评分指数、焦虑自评量表(SAS)评分、扩充神经功能残疾量表(EDSS)评分及病程等SF-36各维度,如生理功能(PF)、情感职能(RE)、社会功能(SF)、精神健康(MH)、生理职能(RP)、精力(VT)、躯体疼痛(BP)、总体健康(GH)等参数,提出MS者SF-36的影响因素。结果 MS患者间歇期越缩短、发作期及病程越延长、SDS及SAS和EDSS评分越高,SF-36各维度评分越降低(P0.05或P0.01)。结论间歇期、发作期、SDS评分指数、SAS及EDSS评分、病程等直接影响MS患者的生活质量。     

社区与住院精神分裂症患者生活质量的比较分析

目的　对社区康复期与住院精神分裂症患者的生活质量进行了调查和比较分析。方法　用健康调查表SF - 36调查社区康复期与住院精神分裂症患者 ,并设正常对照组。结果　正常对照组的SF - 36因子分体能(PF)、体能影响 (RP)、一般健康 (GH)、社会活动 (SF)、心理健康 (MH)均高于社区康复期精神分裂症患者 ,差异有极显著性 (P <0 0 1) ;正常对照组在体能 (PF)、体能影响 (RP)、社会活动 (SF)因子分均高于住院治疗期精神分裂症患者 ,差异有极显著性 (P <0 0 1) ;社区康复期精神分裂症患者在体能 (PF)、体能影响 (RP)、精神影响 (RE)分高于住院治疗期精神分裂症患者 ,且差异有极显著性 (P <0 0 1) ,而后者一般健康 (GH)、精力 (VT)、心理健康 (MH)分高于前者 ,且差异有显著性 (P <0 0 5 )。结论　社区康复期精神分裂症患者在躯体健康方面优于住院治疗期精神分裂症患者 ,后者在精神健康方面优于社区康复期精神分裂症患者。     

难治性强迫症患者生命质量及影响因素

目的 探讨难治性强迫症患者生命质量及影响因素.方法 入组43例难治性强迫症患者进行SF-36Yale-Brown强迫量表(YBOCS)评定,对SF-36量表分值与一般情况进行相关性分析.结果 难治性强迫症患者组SF-36量表分值与正常人群相比,在生理职能(RP)、社会功能(SF)、情感职能(RE)、精神健康(MH)维度分数[(67.4±44.1)分,(70.0±29.8)分,(46.5±41.8)分,(47.7±17.1)分]均低于普通人群,而且差异均有显著性(P<0.05).有工作难治性强迫症患者在生理职能(RP)、社会功能(SF)维度分数[(81.2±33.9)分,(81.2±22.1)分]显著高于无工作患者(P<0.05).结论 难治性强迫症患者生命质量较正常人群差.起病年龄、是否工作与其生命质量相关.     

焦虑症患者防御方式与生活质量特征的调查分析

目的探讨焦虑症患者防御方式及生活质量特征。方法分别运用防御方式问卷(QSD)和健康调查问卷(SF-36)对20例焦虑症患者和18例正常对照进行防御机制评定和生活质量调查。结果(1)焦虑症患者较多使用幻想、升华、制止、交往倾向等防御机制。(2)对照组SF-36因子分一般健康(GH)、精力(VT)、社会功能(SF)、情感职能(RE)、精神健康(MH)显著高于焦虑症患者(P<0.01)。(3)焦虑症患者精力(VT)、情感职能(RE)与不成熟防御机制有密切关系。结论焦虑症患者较多使用不成熟的、中间型的防御机制,并影响其生活质量、心理健康。     

社区2型糖尿病患者生活质量状况及影响因素分析

目的调查社区2型糖尿病患者的生活质量状况并探讨其影响因素。方法采用单纯随机抽样法从上海市杨浦区三个社区抽取210名糖尿病患者(研究组),采用健康状况量表(SF-36)、社会支持评定量表(SSRS)、焦虑自评量表(SAS)、抑郁自评量表(SDS)、家庭功能评定量表(FAD)对患者进行评定,并与210例健康人群(对照组)进行对照。结果研究组SF-36的躯体健康所致的角色限制(RP)、总体健康感(GH)、社交功能(SF)、心理健康(MH)及生活质量总评分(SF-36)与对照组比较差异有统计学意义(P0.05或0.01);多因素逐步回归分析显示影响患者生活质量的主要因素依次为SAS、SDS、有无并发症、FAD(P0.01)。结论社区2型糖尿病患者的生活质量较差,焦虑抑郁等负性情绪、并发症的发生、家庭功能障碍是影响患者生活质量的重要因素,在社区康复过程中应予以重视。     

血栓通治疗老年脑梗死后遗症的综合评价

目的探讨血栓通对老年脑梗死后遗症患者的疗效及生活质量的干预作用。方法将73例脑梗死后遗症患者按照入院先后顺序分为观察组（37例）和对照组（36例）。两组患者均给予脑蛋白水解物注射液治疗,观察组在此基础上加用血栓通治疗。疗程为2周,两疗程后评价疗效,两疗程间间隔2周。治疗结束后根据症状变化评定疗效,并采用36条目健康调查简表（SF-36）对患者进行生活质量评价。结果观察组有效率为91.89%,对照组有效率为72.22%,两组差异有统计学意义（P〈0.05）;观察组SF-36评分方面,生理功能（PF）、生理职能（RP）、躯体疼痛（BP）、总体健康（GH）、情感职能（RE）、社会功能（SF）、活力（VT）及精神健康（MH）的评分均高于对照组,差异均有统计学意义（P〈0.05）。结论血栓通治疗脑梗死后遗症疗效肯定,并可明显改善患者的生活质量。     

滋肾柔肝汤对精神病药物所致高催乳素血症患者生活质量的影响

目的探讨滋肾柔肝汤对精神病药物所致高催乳素血症患者生活质量的影响。方法应用随机、双盲、病例对照研究方法,将120例抗精神病药物所致高催乳素血症患者随机分成研究组58例和对照组62例,分别使用滋肾柔肝汤和安慰剂治疗。疗程为12周,在基线、4周、8周和12周末时,对两组血清催乳素（PRL）、阳性与阴性症状量表（PANSS）及健康状况问卷（SF-36）等进行评定。结果治疗后两组间疗效比较存在显著统计学差异（P=0．000）。治疗前后,患者PANSS评分没有统计学差异（P〉0．05）。与治疗前相比,治疗后研究组在躯体功能（PF）、躯体职能（RP）、躯体疼痛（BP）、总体健康（GH）、生命活力（VT）、社交功能（SF）、情感职能（RE）、精神健康（MH）、躯体健康总评（PCS）和精神健康总评（MCS）等评分均明显升高（P〈0．05）;治疗前后对照组SF-36评分没有明显差异（P〉0．05）。治疗前两组间SF-36比较没有统计学差异;治疗后,研究组在PF、RP、GH、VT、MH、HT、PCS和MCS评分均明显高于对照组,差异有统计学意义（P〈0．05）。结论滋肾柔肝汤治疗抗精神痛药物所致高催乳素血症的疗效显著,精神症状无反复,可以明显改善抗精神病药物所致高催乳素患者的生活质量。     

奥拉西坦对脑梗死后遗症患者生活质量疗效观察

目的 观察奥拉西坦注射液对脑梗死后遗症活质量的影响.方法 112例急性脑梗死患者随机分为治疗组(58例)和对照组(54例);对照组给予血塞通注射液500 mg,静滴, 1次/d;给予阿司匹林100 mg,1次/d,口服,疗程4周;治疗组在对照组基础上给予奥拉西坦注射液4 g,1次/d,疗程4周.治疗前后分别进行巴氏指数和神经功能缺损评分,并进行SF-36测评.结果 治疗组神经功能缺损程度评分及巴氏指数评分明显高于对照组,差异有统计学意义(P<0.05);治疗后,治疗组SF-36评分,PF、RP、RE、SF、BP、VT、MH及GH的平均评分均高于对照组,差异有统计学意义(P<0.05).结论 奥拉西坦注射液能明显改善患者的生活质量,适宜推广应用.     

SF-36量表测定重症肌无力患者生活质量分析

目的 探讨 SF-36 量表测定重症肌无力患者的生活质量,以寻找良好的疾病严重度评估标准.方法 采用SF-36量表对重症肌无力患者和健康对照人群进行面对面问卷调查,比较重症肌无力患者与健康对照人群组间,眼肌型与全身型患者之间在躯体功能、社会功能等8 个维度方面的区别.结果 (1)重症肌无力患者SF-36 量表各维度Cronbach's α系数均大于或接近0.7; 健康对照人群组除活力(VT)和社会功能(SF)维度外,其他维度Cronbach's α系数均大于0.7.(2)健康对照人群组躯体角色(RP)、情绪角色(RE)、活力(VT)、社会功能(SF)、躯体功能(PF)、维度得分显著高于重症肌无力患者.(3)眼肌型患者与全身型患者的生活质量比较差异无统计学意义.结论 SF-36 测定中国重症肌无力患者中使用具有较好的信度,可作为疾病严重程度的评估标准.     

焦虑症患者的生活质量及相关因素分析

目的 探索焦虑症患者的生活质量及相关因素。方法 对60例符合CCMD-3诊断标准的焦虑症患者进行一般情况调查、汉密顿焦虑量表（HAMA）、汉密顿抑郁量表（HAMD）、健康状况调查问卷（SF-36）评定。结果除生理机能一项外，焦虑症患者SF-36各维度的评分均显著低于常模（P〈0．01）。患者HAMD评分和SF-36各维度评分呈显著负相关（P〈0．05或P〈0．01）。伴有抑郁症状的焦虑症患者，其SF-36的躯体疼痛、一般健康状况、精力、社会功能、情感职能、精神健康6个维度得分显著低于不伴抑郁症状的患者（P〈0．05或P〈0．01），其HAMA评分显著高于不伴抑郁症状的患者（P〈0．01）。结论 焦虑症患者的生活质量低于一般正常人群，伴有的抑郁症状的焦虑症患者其生活质量受损更加严重。     

伴与不伴糖尿病的精神分裂症生活质量的比较

目的 探讨精神分裂症伴发糖尿病对生活质量的影响.方法 对86例伴糖尿病的精神分裂症与128例无糖尿病也无糖耐量异常的精神分裂症采用阳性与阴性症状量表及健康状况问卷评定临床症状与生活质量.结果 健康问卷的生理机能、躯体疼痛、一般健康及精神健康评分伴糖尿病组显著低于不伴糖尿病组(P＜0.05).生理机能、躯体疼痛及精神健...     

持续性躯体形式疼痛障碍生命质量的相关因素研究

目的探讨持续性躯体形式疼痛障碍（persist somatoform pain disorder，PSPD）患者的生命质量及相关因素。方法采用横断面调查研究，对60例PSPD患者应用健康状况调查问卷（SF-36）评定其生命质量，医疗结局研究用疼痛量表（MOSPM）评定PSPD严重程度，汉密顿抑郁量表（HAMD17），汉密顿焦虑量表（HAMA）评定伴随的情绪状态。结果（1）除精神健康和精力分量表外，SF-36各分量表评分均显著低于普通居民（P〈0．01）；（2）除一般健康状况分量表外，SF-36各分量表评分与MOSPM总分及各因子分均显著负相关，与HAMD17及HAMA总分显著负相关；（3）除一般健康状况分量表外，有抑郁组的SF-36各分量表、躯体健康总评（PCS）及精神健康总评（MCS）分均显著低于无抑郁组（P〈0．01）；（4）多元逐步回归结果，SF-36的PCS与年龄和MOSPM总分相关，MCS则与HAMD总分和MOSPM总分相关。结论PSPD患者的生命质量显著低于普通人群，疼痛症状、抑郁和焦虑情绪与患者的生命质量密切相关，年龄、疼痛、抑郁为PCS和MCS重要影响因素。     

Life space and mental health: a study of older community-dwelling persons in Australia

Objectives: The ability of older people to mobilise within and outside their community is dependent on a number of factors. This study explored the relationship between spatial mobility and psychological health among older adults living in Australia.Methods: The survey sample consisted of 260 community-dwelling men and women aged 75–80 years, who returned a postal survey measuring spatial mobility (using the Life Space Questionnaire) and psychological health (using the SF36 Health Related Quality of Life Profile). From the Life Space Questionnaire, participants were given a life-space score and multinomial regression was used to explore the potential effect of mental health on life-space score.Results: The study found a significant association between mental health and life space. However, gender, physical functioning, and ability to drive were most strongly associated with the extent of life space and spatial mobility. Compared to men, older women are more likely to experience less spatial mobility and restricted life space, and hence are more vulnerable to social isolation.Conclusion: Mental health and life space were associated for the older people in this study. These findings have important implications for health policy and highlight the need to support older persons to maintain independence and social networks, and to successfully age in place within their community. This study also highlights the utility of the Life Space Questionnaire in terms of identifying older persons at risk of poorer mental health.     

Physical and mental health status of staff working for people with intellectual disabilities in Taiwan: measurement with the 36-Item Short-Form (SF-36) health survey

Little explicit attention has been given to the generic health profile of staff working for people with intellectual disability in institutions. This study aimed to provide a profile of physical and mental health of staff working in disability welfare institutions, and to examine the possible demographic and organizational factors that explain an association with their health. A cross-sectional questionnaire survey was conducted to analyze 1243 staff (76% response rate) working in 24 institutions in Taiwan. The 36-Item Short-Form (SF-36) Taiwan version was used to measure their generic health status. The mean of Physical component scores (PCS) was slightly higher than Mental component scores (MCS) (50.83 vs. 45.12). With regard to each dimension among PCS, the mean score of Physical functioning (PF) was 57.14 (S.D.=5.93), Role limitations-physical (RP) was 49.88 (S.D.=9.69), Bodily pain (BP) was 52.14 (S.D.=8.09) and General medical health (GH) was 51.50 (S.D.=8.28). Among the MCS, Vitality (VT) was 46.19 (S.D.=6.71); Social functioning (SF) was 46.44 (S.D.=7.58); Role limitations-emotional (RE) was 47.30 (S.D.=11.89) and Mental health (MH) was 43.58 (S.D.=8.81). We found the generic health of staff working for people with intellectual disabilities were significantly lower in PCS and MCS than the Taiwan general population. Influences of staff's demographic and organizational characteristics on their health were also analyzed in the content. This study highlights the authorities and service providers need to continue to develop their awareness and understanding of the experiences that their staff encounters in the organizations, so that they can receive resources to support their positive health in working for people with intellectual disabilities.     

Quality of life in patients with focal dystonia

Objectives

The aims of this study were to identify the clinical and demographic factors influencing health-related quality of life (HR-QoL) and to compare HR-QoL measures between various types of focal dystonia (cervical dystonia, blepharospasm, and writer’s cramp).

Methods

We examined 157 consecutive patients with adult-onset primary focal dystonia, and HR-QoL was assessed by using the SF-36 questionnaire. Univariate and multivariate regression analyses were performed.

Results

Patients with writer’s cramp scored better in all SF-36 domains, except role functioning physical (RP), while these differences were statistically significant for physical functioning (PF) (p = 0.020), bodily pain (BP) (p = 0.001), and general health (GH) (p = 0.004). Patients with writer’s cramp and blepharospasm scored significantly better for BP (p = 0.001) than patients with cervical dystonia. We found that each of the eight dimensions of SF-36 proved to be significantly correlated to the Hamilton depression rating scale score in patients with torticollis and blepharospsm, while vitality (VT), social functioning (SF), and mental health (MH) scales showed statistically significant correlations in patients with hand dystonia. Similar relationships were observed between anxiety and SF-36 domains.

Conclusion

Depression and anxiety are the most important predictors of poorer HR-QoL in patients with all three types of focal dystonia.     

Health-related quality of life and depressive symptoms in significant others of people with multiple sclerosis: a community study

Background and purpose: Uncertain prognosis and modest treatment efficacy make multiple sclerosis (MS) a particularly difficult disease to adjust to for both patients and their significant others (SOs). Few studies have assessed health‐related quality of life (HRQOL) and depressive symptoms in SOs of people with MS in the community. We assessed, and identified predictors of, HRQOL and depression in SOs of adults with MS. Methods: POSMOS (postal survey of self‐assessed health in MS adults and SOs) is a longitudinal survey on a random sample of 251 people with MS in the Milan area. In 2010, SOs and contemporaneous controls completed the SF‐36 and Chicago Multiscale Depression Inventory (CMDI). Results: Overall, 142 SOs (mean age 53.1 years; 50% women, 65% partners) and 120 controls (similar to SOs for sex and education, but older) participated. By multivariable modeling of the SO plus control population, SF‐36 vitality was lower in SOs (proportional odds ratio 0.45; 95% confidence interval 0.28–0.70), women (0.41; 0.27–0.64), and older subjects (0.98; 0.97–0.99). SF‐36 mental health was also lower in SOs (0.62; 0.40–0.96) and women (0.43; 0.28–0.67). Regarding MS characteristics associated with HRQOL and depression in SOs, severe disability [Expanded Disability Status Scale (EDSS > 6.5)] had no effect, whilst depressive symptoms (pathologic CMDI) negatively influenced most SF‐36 and all CMDI scores in SOs. Conclusions: SOs had significantly lower vitality and psychological well‐being than controls, identifying a burden in being the companion of a person with MS. This burden was unrelated to physical compromise but associated with depressive symptoms in MS.     

米氮平治疗广泛性焦虑症患者的临床疗效及对患者防御方式与生活质量的改变

目的研究米氮平对广泛性焦虑症的治疗效果,并探讨其对患者防御方式与生活质量的影响。方法对32例广泛性焦虑症患者给予米氮平治疗,于治疗前和第1、2、4、6周末利用汉密顿焦虑量表（HAMA）评估临床疗效,同时在治疗前和治疗第6周末进行防御方式（DSQ量表）和生活质量（SF-36量表）调查。结果32例广泛性焦虑症患者中痊愈21例（65．6％）,显著进步7例（21．9％）,有效4例（12．5％）,显效率达87．5％,有效率达100％。第1、2、4、6周末与治疗前相比,HAMA评分均具有显著性差异（P〈0.05）;不良反应较少。与治疗前相比,第6周末患者成熟型防御机制评分升高,不成熟型和中间型防御机制评分降低,差异均有统计学意义（P〈0.05）;生活质量评估中一般健康（GH）、精力（VT）、社会功能（SF）、情感职能（RE）、精神健康（MH）等评分也均升高（P〈0．05）。结论米氮平能快速有效地治疗广泛性焦虑症,而且能促进患者防御机制向成熟型转变,提高生活质量。     

Body mass index and quality of life in community-dwelling patients with schizophrenia

OBJECTIVE: To examine the associations between sociodemographic variables, body weight and quality of life in schizophrenic outpatients. METHODS: Assessments included an interview to obtain sociodemographic data, administration of a Quality of Life questionnaire (the MOS SF-36) and measurement of height and weight. Body mass index was calculated (kg/m(2)). SF-36 subscores were examined for statistical differences based on BMI categories: healthy weight (BMIor=30). Correlations with sociodemographic variables were also examined. RESULTS: Body weight was inversely correlated (level p相似文献   

Untreated depressive symptoms among cognitively-intact, community dwelling Filipino patients with Parkinson disease

The objective of this study is to determine the prevalence of depressive symptoms and its correlation with the quality of life among cognitively intact, community dwelling Filipino patients with Parkinson disease (PD) not treated pharmacologically for depression. In this prospective, cross-sectional study 76 PD patients were included. Demographic data were obtained including: age, gender, onset of disease, disease duration, and medication intake. The Mini Mental State Examination (MMSE) was performed to exclude significant cognitive impairment. The Montgomery Asberg Depression Rating Scale (MADRS) was administered to quantify the degree of depressive symptoms. The degree of depressive symptoms was correlated with the SF 36 and UPDRS Parts II and III. Our cohort of patients had a mean age of 61 years (range: 42-81 years), and disease duration of 2.7 years (33 months); 46 (61%) experienced significant depressive symptoms based on the MADRS cutoff score of >14. Depressive symptoms were associated with poorer performance on both UPDRS Parts II and III and SF 36. Untreated depressive symptoms among Filipinos with PD may be higher compared to other PD populations but prospective and age-matched controlled studies will need to be performed to confirm these preliminary observations. The presence of depressive symptoms was significantly correlated with poorer quality of life and level of functioning.